Entera Bio Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Entera Bio Ltd., a foreign private issuer, for the month of August 2020. The filing, dated August 5, 2020, serves primarily to incorporate a press release issued on the same date by reference. The registrant is headquartered in Jerusalem, Israel, and files annual reports on Form 20-F.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to distribute a press release and does not contain a financial statement or detailed financial data within the provided text.
Material Changes
The filing text does not provide a clear value regarding material changes versus the prior comparable period. The content is limited to the incorporation of an external press release (Exhibit 99.1) without summarizing its specific financial or operational details.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. While the filing incorporates a press release by reference, the specific content of that release is not included in the provided text.
Key Facts for Investor Verification
- Verify the content of the press release dated August 5, 2020, attached as Exhibit 99.1, as this filing contains no substantive operational details.
- Confirm the company's status as a foreign private issuer filing under Form 20-F.
- Note that this filing incorporates the press release into pending registration statements on Form F-3 (Registration Numbers 333-238988 and 333-239843).
- Review the signature of Adam Gridley, Chief Executive Officer, dated August 5, 2020.